D.D. Breimer

2.8k total citations
89 papers, 2.4k citations indexed

About

D.D. Breimer is a scholar working on Pharmacology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, D.D. Breimer has authored 89 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 20 papers in Pharmacology and 19 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in D.D. Breimer's work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (15 papers) and Epilepsy research and treatment (15 papers). D.D. Breimer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (15 papers) and Epilepsy research and treatment (15 papers). D.D. Breimer collaborates with scholars based in Netherlands, Germany and United Kingdom. D.D. Breimer's co-authors include Meindert Danhof, M. W. E. Teunissen, P. van Brummelen, C. H. Kleinbloesem, Albertus G. de Boer, P.A. Soons, Nico Vermeulen, J.M. van Rossum, Leo G. J. de Leede and T. B. Vree and has published in prestigious journals such as Journal of Controlled Release, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

D.D. Breimer

89 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.D. Breimer Netherlands 27 510 501 444 381 334 89 2.4k
J. H. G. Jonkman Netherlands 29 571 1.1× 428 0.9× 401 0.9× 343 0.9× 382 1.1× 115 2.4k
Allen J. Sedman United States 32 531 1.0× 661 1.3× 513 1.2× 420 1.1× 603 1.8× 86 3.2k
C G Regårdh Sweden 28 798 1.6× 468 0.9× 401 0.9× 776 2.0× 438 1.3× 59 2.8k
B. Oosterhuis Netherlands 25 634 1.2× 333 0.7× 370 0.8× 426 1.1× 377 1.1× 74 2.1k
B Beermann Sweden 27 358 0.7× 388 0.8× 380 0.9× 229 0.6× 403 1.2× 98 2.4k
Peter G. Dayton United States 32 587 1.2× 554 1.1× 449 1.0× 407 1.1× 702 2.1× 109 3.1k
Hermann R. Ochs United States 30 553 1.1× 497 1.0× 409 0.9× 313 0.8× 366 1.1× 117 2.8k
Douglas E. Rollins United States 35 825 1.6× 430 0.9× 354 0.8× 296 0.8× 476 1.4× 113 3.4k
L Balant Switzerland 26 422 0.8× 370 0.7× 176 0.4× 257 0.7× 395 1.2× 85 1.9k
Thorir D. Bjornsson United States 28 666 1.3× 295 0.6× 244 0.5× 470 1.2× 466 1.4× 72 2.8k

Countries citing papers authored by D.D. Breimer

Since Specialization
Citations

This map shows the geographic impact of D.D. Breimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.D. Breimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.D. Breimer more than expected).

Fields of papers citing papers by D.D. Breimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.D. Breimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.D. Breimer. The network helps show where D.D. Breimer may publish in the future.

Co-authorship network of co-authors of D.D. Breimer

This figure shows the co-authorship network connecting the top 25 collaborators of D.D. Breimer. A scholar is included among the top collaborators of D.D. Breimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.D. Breimer. D.D. Breimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breimer, D.D.. (1999). Future challenges for drug delivery. Journal of Controlled Release. 62(1-2). 3–6. 52 indexed citations
2.
Sakai, Michinori, A.B.J. Noach, Margret C.M. Blom-Roosemalen, A.G. de Boer, & D.D. Breimer. (1994). Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers. Biochemical Pharmacology. 48(6). 1199–1210. 17 indexed citations
3.
Mulders, T. M. T., Ben van Ommen, Peter J. van Bladeren, D.D. Breimer, & Gerard J. Mulder. (1993). Stereoselectivity of human liver and intestinal cytosolic fractions as well as purified human glutathione S-transferase isoenzymes towards 2-bromoisovalerylurea enantiomers. Biochemical Pharmacology. 46(10). 1775–1780. 7 indexed citations
4.
Soons, P.A., AF Cohen, & D.D. Breimer. (1993). Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers. European Journal of Clinical Pharmacology. 44(2). 113–120. 6 indexed citations
5.
Roos, R. A. C., Marina A.J. Tijssen, E. A. van der Velde, & D.D. Breimer. (1993). The influence of a standard meal on Sinemet CR absorption in patients with Parkinson's disease. Clinical Neurology and Neurosurgery. 95(3). 215–219. 7 indexed citations
6.
Stark, Holger, et al.. (1992). In vitro penetration of des-tyrosine1-D-phenylalanine3-β-casomorphin across the blood-brain barrier. Peptides. 13(1). 47–51. 3 indexed citations
7.
Soons, P.A., Tobias Ankermann, D.D. Breimer, & Wilhelm Kirch. (1992). Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function. European Journal of Clinical Pharmacology. 42(4). 423–427. 5 indexed citations
8.
Irth, Hubertus, U.R. Tjaden, J. van der Greef, et al.. (1992). Enantioselective determination of R- and S-(α-bromoisovaleryl)urea in plasma using high-performance liquid chromatography after solid-phase extraction. Journal of Chromatography B Biomedical Sciences and Applications. 573(2). 259–264. 5 indexed citations
9.
Schellens, Jan H.M., et al.. (1991). Nonlinear first-pass metabolism of nifedipine in healthy subjects. Xenobiotica. 21(4). 547–555. 8 indexed citations
10.
Boer, Anthonius de, et al.. (1990). Interaction of the Combined Medication with the New Low-Molecular-Weight Heparinoid Lomoparan® (Org 10172) and Acenocoumarol. Pathophysiology of Haemostasis and Thrombosis. 20(3). 136–146. 2 indexed citations
11.
Soons, P.A., Jeffrey Kroon, & D.D. Breimer. (1990). Effects of Single‐Dose and Short‐Term Oral Nifedipine on Indocyanine Green Clearance as Assessed by Spectrophotometry and High Performance Liquid Chromatography. The Journal of Clinical Pharmacology. 30(8). 693–698. 12 indexed citations
12.
Harten, J. Van, et al.. (1989). Variability in the Pharmacokinetics of Nisoldipine as Caused by Differences in Liver Blood Flow Response. The Journal of Clinical Pharmacology. 29(8). 714–721. 9 indexed citations
13.
Dingemanse, Jasper, et al.. (1988). Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure. Journal of Pharmacokinetics and Biopharmaceutics. 16(2). 203–228. 26 indexed citations
14.
Schellens, Jan H.M., P.A. Soons, & D.D. Breimer. (1988). Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. Biochemical Pharmacology. 37(13). 2507–2510. 78 indexed citations
15.
Schellens, J., et al.. (1987). Mephenytoin polymorphism in relation to methylphenytoin phenytoin and phenobarbital hydroxylation. Clinical Pharmacology & Therapeutics. 41(2). 158. 3 indexed citations
16.
Graaff, M. van der, Nico Vermeulen, & D.D. Breimer. (1986). Intra-arterial administration of hexobarbital enantiomers to the rat: disposition and estimation of apparent extraction ratio. Pharmacy World & Science. 8(2). 139–144. 1 indexed citations
17.
Teunissen, M. W. E., et al.. (1985). Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.. Journal of Pharmacology and Experimental Therapeutics. 233(3). 770–775. 33 indexed citations
18.
Danhof, Meindert, et al.. (1981). Influence of the Genetically Controlled Deficiency in Debrisoquine Hydroxylation on Antipyrine Metabolite Formation. Pharmacology. 22(6). 349–358. 26 indexed citations
19.
Breimer, D.D., et al.. (1973). Relative bioavailability of chloral hydrate after rectal administration of different dosage forms. Radboud Repository (Radboud University). 108. 1101–1110. 6 indexed citations
20.
Vree, T. B., D.D. Breimer, C. A. M. van Ginneken, et al.. (1972). Chemie en farmakokinetiek van hashish en marihuana bestanddelen. Data Archiving and Networked Services (DANS). 68. 1–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026